Navigating the Latest Options for the Treatment of CKD in T2D

In this series of microlearning modules expert faculty provide insight on new evidence and treatment for chronic kidney disease in type 2 diabetes to improve kidney and cardiovascular outcomes.

Share

Program Content

Activities

SGLT2i in T2D With CKD
Role of SGLT2 Inhibitors in Type 2 Diabetes With Chronic Kidney Disease
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 12, 2022

Expires: July 11, 2023

View Activity
Slides: SGLT2i in T2D With CKD
Role of SGLT2 Inhibitors in Type 2 Diabetes With Chronic Kidney Disease
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 12, 2022

Expires: July 11, 2023

View Activity
Commentary: SGLT2 Inhibitors in DKD
Tips on Prescribing SGLT2 Inhibitors in Diabetic Kidney Disease
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 21, 2022

Expires: July 20, 2023

View Activity

Activities

Slides: MRA in T2D CKD
Nonsteroidal Mineralocorticoid Receptor Antagonist in Type 2 Diabetes–Associated Chronic Kidney Disease
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2022

Expires: July 06, 2023

View Activity
MRA in T2D CKD
Nonsteroidal Mineralocorticoid Receptor Antagonist in Type 2 Diabetes–Associated Chronic Kidney Disease
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

View Activity
Finerenone in T2D CKD
Evidence for Use of Finerenone in T2D-associated CKD
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

View Activity

Activities

Management of T2D and CKD
How Should We Individualize Management for Patients With Type 2 Diabetes and CKD?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 14, 2022

Expires: September 13, 2023

View Activity
Management in T2D with CKD
Individualizing Management in T2D With CKD
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: September 21, 2022

Expires: September 20, 2023

View Activity
Management in T2D with CKD
Individualizing Management in T2D With CKD
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 21, 2022

Expires: September 20, 2023

View Activity

Faculty

cover img faculity

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

cover img faculity

Jennifer B. Green, MD

Professor of Medicine
Division of Endocrinology
Department of Medicine
Duke Clinical Research Institute
Duke University Medical Center
Durham, North Carolina

cover img faculity

Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP

Vice Chair & Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
Spokane, Washington

Provided by

ProCE Banner

Supporters

This activity is supported by independent educational grants from

Bayer HealthCare Pharmaceuticals Inc.

Boehringer Ingelheim and Eli Lilly